News & Updates

Dolutegravir remains noninferior to low-dose efavirenz for HIV-1 after 96 weeks

19 Aug 2020 by

A dolutegravir-based regimen continued to show noninferiority to a low-dose efavirenz-based regimen after 96 weeks for the initial treatment of HIV-1 infection, according to the updated results of the NAMSAL* trial presented at AIDS 2020.

Dolutegravir remains noninferior to low-dose efavirenz for HIV-1 after 96 weeks

19 Aug 2020

Smell, taste dysfunction among COVID-19 patients unrelated to viral load

19 Aug 2020 by

Although olfactory and gustatory dysfunctions are common among patients with the coronavirus disease 2019 (COVID-19), they do not exhibit a clear connection to viral load, according to a recent study.

Smell, taste dysfunction among COVID-19 patients unrelated to viral load

19 Aug 2020

A new molecule has been approved in Europe for the treatment of drug resistant TB.

19 Aug 2020 by

A new compound has been granted conditional marketing authorization by the European Commission (EC) for treating highly drug-resistant forms of pulmonary tuberculosis (TB).

A new molecule has been approved in Europe for the treatment of drug resistant TB.

19 Aug 2020

Novel triple therapy eradicates Helicobacter pylori

19 Aug 2020

A new three-drug combination therapy for the treatment of Helicobacter pylori infection is currently in phase 3 clinical trials. The combination RHB-105, consisting of amoxicillin (3 g), omeprazole (120 mg), and rifabutin (150 mg) in a single-dose capsule, achieved high eradication rates of H. pylori infection. [Ann Intern Med 2020;172(12):795–802]

Novel triple therapy eradicates Helicobacter pylori

19 Aug 2020

Onsite, lab-free testing of COVID-19 being tested in London hospitals

19 Aug 2020

A new, lab-free COVID-19 test is now being distributed to selected hospitals across London. The new test is called COVID Nudge and claims to offer “gold-standard accuracy” and a processing time from sample collection to results in about an hour. [Available at: https://imperialbrc.nihr.ac.uk/2020/06/01/lab-free-covid-19-test-trialled-in-london-hospitals/ Accessed on 13 August 2020]

Onsite, lab-free testing of COVID-19 being tested in London hospitals

19 Aug 2020

COVID-19 vaccine: Consider oral immunization

18 Aug 2020 by

As the global race for the first effective vaccine against the novel coronavirus disease (COVID-19) carries on, a team of UK researchers suggests that the development of an oral formulation be given a chance because of certain advantages concerning safety, efficacy, compliance, ease of manufacturing, and administration relative to an injectable approach.

COVID-19 vaccine: Consider oral immunization

18 Aug 2020

HCV eradication reduces risks of gastric cancer, non-Hodgkin lymphoma

18 Aug 2020

Eradication of hepatitis C virus (HCV) leads to a lower risk of gastric cancer and non-Hodgkin lymphoma (NHL), particularly among younger patients, a Taiwan study has shown. This indicates that those with chronic HCV infection must be treated as early as possible.

HCV eradication reduces risks of gastric cancer, non-Hodgkin lymphoma

18 Aug 2020

COVID-19: COPD patients, smokers may fare badly

18 Aug 2020

Among patients with COVID-19, those with underlying respiratory diseases, particularly chronic obstructive pulmonary disorder (COPD), and tobacco users are likely to have severe outcomes, according to the results of a systematic review and meta-analysis.

COVID-19: COPD patients, smokers may fare badly

18 Aug 2020

The controversies surrounding hydroxychloroquine may prevent it from realizing its full potential as a cheap and effective COVID-19 medication.

18 Aug 2020 by

The recent controversies surrounding hydroxychloroquine—including fraudulent data, unjustified extrapolation and exaggerated safety concerns—coupled with intense politicization and negative publicity, may prevent the medication from saving thousands of lives, say researchers.

The controversies surrounding hydroxychloroquine may prevent it from realizing its full potential as a cheap and effective COVID-19 medication.

18 Aug 2020

Flu, pneumococcal vaccines may prevent Alzheimer’s disease

17 Aug 2020 by

Regular influenza and pneumococcal vaccinations may help stave off the development of Alzheimer’s disease (AD), according to two studies presented at AAIC 2020.

Flu, pneumococcal vaccines may prevent Alzheimer’s disease

17 Aug 2020

News & Updates

Filter by Specialty:

Specialty:

Dolutegravir remains noninferior to low-dose efavirenz for HIV-1 after 96 weeks

Dolutegravir remains noninferior to low-dose efavirenz for HIV-1 after 96 weeks

Smell, taste dysfunction among COVID-19 patients unrelated to viral load

Smell, taste dysfunction among COVID-19 patients unrelated to viral load

A new molecule has been approved in Europe for the treatment of drug resistant TB.

A new molecule has been approved in Europe for the treatment of drug resistant TB.

Novel triple therapy eradicates Helicobacter pylori

Novel triple therapy eradicates Helicobacter pylori

Onsite, lab-free testing of COVID-19 being tested in London hospitals

Onsite, lab-free testing of COVID-19 being tested in London hospitals

COVID-19 vaccine: Consider oral immunization

COVID-19 vaccine: Consider oral immunization

HCV eradication reduces risks of gastric cancer, non-Hodgkin lymphoma

HCV eradication reduces risks of gastric cancer, non-Hodgkin lymphoma

COVID-19: COPD patients, smokers may fare badly

COVID-19: COPD patients, smokers may fare badly

The controversies surrounding hydroxychloroquine may prevent it from realizing its full potential as a cheap and effective COVID-19 medication.

The controversies surrounding hydroxychloroquine may prevent it from realizing its full potential as a cheap and effective COVID-19 medication.

Flu, pneumococcal vaccines may prevent Alzheimer’s disease

Flu, pneumococcal vaccines may prevent Alzheimer’s disease